Statins in acute coronary syndrome: very early initiation and benefits.

@article{Angeli2012StatinsIA,
  title={Statins in acute coronary syndrome: very early initiation and benefits.},
  author={Fabio Angeli and Gianpaolo Reboldi and Giovanni Mazzotta and Marta Garofoli and Maria Francesca Cerasa and Paolo Verdecchia},
  journal={Therapeutic advances in cardiovascular disease},
  year={2012},
  volume={6 4},
  pages={163-74}
}
The use of 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins) is associated with a marked reduction in morbidity and mortality in patients at high cardiovascular risk or with established cardiovascular disease. In the last decade, several randomized controlled studies have demonstrated the benefit of statins in patients with acute coronary syndrome (ACS). These studies showed that use of statins in patients with ACS is associated with a significant reduction of the risk of recurrent… CONTINUE READING